694 related articles for article (PubMed ID: 29186759)
1. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.
Jamilian M; Foroozanfard F; Rahmani E; Talebi M; Bahmani F; Asemi Z
Nutrients; 2017 Nov; 9(12):. PubMed ID: 29186759
[TBL] [Abstract][Full Text] [Related]
2. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Maktabi M; Chamani M; Asemi Z
Horm Metab Res; 2017 Jul; 49(7):493-498. PubMed ID: 28679140
[TBL] [Abstract][Full Text] [Related]
4. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
[TBL] [Abstract][Full Text] [Related]
5. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome.
Jamilian M; Samimi M; Mirhosseini N; Afshar Ebrahimi F; Aghadavod E; Talaee R; Jafarnejad S; Hashemi Dizaji S; Asemi Z
J Affect Disord; 2018 Oct; 238():32-38. PubMed ID: 29859385
[TBL] [Abstract][Full Text] [Related]
6. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Foroozanfard F; Talebi M; Samimi M; Mehrabi S; Badehnoosh B; Jamilian M; Maktabi M; Asemi Z
Horm Metab Res; 2017 Aug; 49(8):612-617. PubMed ID: 28679142
[TBL] [Abstract][Full Text] [Related]
7. Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.
Maktabi M; Jamilian M; Asemi Z
Biol Trace Elem Res; 2018 Mar; 182(1):21-28. PubMed ID: 28668998
[TBL] [Abstract][Full Text] [Related]
8. Effects of Probiotic Supplementation on Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Karamali M; Eghbalpour S; Rajabi S; Jamilian M; Bahmani F; Tajabadi-Ebrahimi M; Keneshlou F; Mirhashemi SM; Chamani M; Hashem Gelougerdi S; Asemi Z
Arch Iran Med; 2018 Jan; 21(1):1-7. PubMed ID: 29664663
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome.
Ostadmohammadi V; Jamilian M; Bahmani F; Asemi Z
J Ovarian Res; 2019 Jan; 12(1):5. PubMed ID: 30665436
[TBL] [Abstract][Full Text] [Related]
10. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Razavi M; Jamilian M; Karamali M; Bahmani F; Aghadavod E; Asemi Z
Horm Metab Res; 2016 Jul; 48(7):446-51. PubMed ID: 27050252
[TBL] [Abstract][Full Text] [Related]
12. Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
Foroozanfard F; Jamilian M; Bahmani F; Talaee R; Talaee N; Hashemi T; Nasri K; Asemi Z; Esmaillzadeh A
Clin Endocrinol (Oxf); 2015 Dec; 83(6):888-94. PubMed ID: 26119844
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Ebrahimi FA; Samimi M; Foroozanfard F; Jamilian M; Akbari H; Rahmani E; Ahmadi S; Taghizadeh M; Memarzadeh MR; Asemi Z
Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):353-359. PubMed ID: 28407657
[TBL] [Abstract][Full Text] [Related]
14. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: A randomized, double blinded, placebo controlled clinical trial.
Mohammad Hosseinzadeh F; Hosseinzadeh-Attar MJ; Yekaninejad MS; Rashidi B
J Trace Elem Med Biol; 2016 Mar; 34():56-61. PubMed ID: 26854246
[TBL] [Abstract][Full Text] [Related]
15. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
Menichini D; Facchinetti F
Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
[TBL] [Abstract][Full Text] [Related]
17. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
[TBL] [Abstract][Full Text] [Related]
18. The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome.
Jamilian M; Mansury S; Bahmani F; Heidar Z; Amirani E; Asemi Z
J Ovarian Res; 2018 Sep; 11(1):80. PubMed ID: 30217229
[TBL] [Abstract][Full Text] [Related]
19. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization.
Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z
Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women.
Asemi Z; Samimi M; Tabassi Z; Shakeri H; Esmaillzadeh A
J Nutr; 2013 Sep; 143(9):1432-8. PubMed ID: 23884390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
